IONS FY 2022 Earnings — Ionis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IONSIonis Pharmaceuticals, Inc.

$13B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$587M-27.5% YoY

Gross Profit

$573M97.6% margin

Operating Income

-$410M-69.8% margin

Net Income

-$270M-45.9% margin

EPS (Diluted)

$-1.90

Cash Flow

Operating Cash Flow

-$274M

Free Cash Flow

-$294M

Stock-Based Comp.

$100M

Balance Sheet

Total Assets

$2.5B

Total Liabilities

$2.0B

Stockholders' Equity

$573M

Cash & Equivalents

$276M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$587M	$810M	-27.5%
Gross Profit	$573M	$800M	-28.3%
Operating Income	-$410M	-$30M	-1258.9%
Net Income	-$270M	-$29M	-843.2%